Llwytho...
Immune checkpoint inhibitors in genitourinary malignancies
Although immune-mediated therapies have been used in genitourinary (gu) malignancies for decades, recent advances with monoclonal antibody checkpoint inhibitors (cpis) have led to a number of promising treatment options. In renal cell carcinoma (rcc), cpis have been shown to have benefit over conven...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Curr Oncol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Multimed Inc.
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7194001/ https://ncbi.nlm.nih.gov/pubmed/32368176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.5121 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|